Twenty-four month, multicenter, prospective, randomized, double-blind, placebo controlled, parallel-group study to evaluate the efficacy, safety, tolerability, and cost-effectiveness of allergen specific sublingual immunotherapy (SLIT) in combination with standard of care (SoC) in pediatric allergic asthma.
Latest Information Update: 30 Jun 2014
At a glance
- Drugs Allergy immunotherapy (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
Most Recent Events
- 30 Jun 2014 New trial record